Related Experiment Video
Updated: Sep 20, 2026

Restraint to Induce Stress in Mice and Rats
Published on: December 6, 2024
Galanin Signaling in Stress-Induced Brain-Gut Axis Dysregulation: Receptor-Specific Mechanisms and Context-Dependent
Enning Zhang1, Zhi Wang1, Haoyue Xu1
1School of Basic Medical Sciences, Capital Medical University, No. 10 Xitoutiao, You'anmenwai, Fengtai District, Beijing 100069, China.
Abstract:
Stress-related dysregulation of the brain-gut axis may help explain the frequent co-occurrence of gastrointestinal disorders and neuropsychiatric phenotypes, including anxiety and depression. Acute and chronic stress can alter gastrointestinal motility, visceral sensation, mucosal barrier integrity, and central affective circuits through the hypothalamic-pituitary-adrenal (HPA) axis, the autonomic nervous system (ANS), immune and inflammatory signaling, and changes in gut microbial ecology. Galanin is distributed across central stress-related nuclei, the enteric nervous system, visceral afferent pathways, and mucosal immune cells, positioning the galanin system as a potential integrator of bidirectional brain-gut signaling. This review examines the expression, receptor biology, and regulatory actions of galanin and its three receptors-galanin receptor 1 (GalR1), galanin receptor 2 (GalR2), and galanin receptor 3 (GalR3)-in stress-induced brain-gut axis dysregulation, while galanin-like peptide (GALP) and spexin provide additional endogenous-ligand context for interpreting GalR pharmacology. The galanin system is neither uniformly protective nor uniformly detrimental. Its functional effects depend on ligand identity, receptor subtype, cell type, anatomical site, stress stage, and inflammatory state, as well as receptor complexes and downstream signaling bias. This context-dependent framework may help identify settings in which galanin-pathway modulation is most mechanistically plausible according to stress stage, inflammatory status, visceral sensitivity, and barrier function. Future studies should prioritize subtype-directed, tissue-restricted, and signaling-biased strategies while maintaining a clear distinction between experimental pharmacological utility, preclinical therapeutic potential, and clinical applicability.
Related Concept Videos
Gut-Brain Axis
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Regulation of Food Intake
Hypothalamic-Pituitary Axis
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
G Protein-coupled Receptors

